sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has made a public disclosure concerning its interest in Spire Healthcare Group plc, as per Rule 8.3 of the UK Takeover Code. Disclosed on February 2, 2026, the submission includes the firm's position as of January 30, 2026. Vanguard is a significant stakeholder, holding 3.58% of Spire's 1p ordinary shares, totaling 14,423,747 shares.
Recent transactions by Vanguard include the purchase of 2,368 shares at 2.05 GBP each and 6,906 shares at 2.07 GBP each. No cash-settled derivative transactions or stock-settled derivative activities involving options were reported.
Vanguard has confirmed the absence of any informal or formal agreements linked to securities. Furthermore, there are no indemnity arrangements or commitments noted in the disclosure.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.